Role of the Blood–Brain Barrier in Multiple Sclerosis

Reactive Oxygen Species and the Central Nervous System

Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947 · see citing works

Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin

Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.7.1539 · Cited by 2,100 · see citing works

Drug Transport across the Blood–Brain Barrier

Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994 · see citing works

Mfsd2a is critical for the formation and function of the blood-brain barrier

Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037 · see citing works

The anatomical and cellular basis of immune surveillance in the central nervous system

Ransohoff, R. M., & Engelhardt, B. (2012) · Nature reviews. Immunology · doi:10.1038/nri3265 · Cited by 975 · see citing works

Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology

Griendling, K. K., Sorescu, D., Lassegue, B. P., & Ushio‐Fukai, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955 · see citing works

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. J., & Mills, K. H. G. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 937 · see citing works

Nitric Oxide Production and Signaling in Inflammation

Korhonen, R., Lahti, A., Kankaanranta, H., & Moilanen, E. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010054526359 · Cited by 920 · see citing works

Nitric oxide and redox mechanisms in the immune response

Wink, D. A., Hines, H. B., Cheng, R. Y. S., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., & Colton, C. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1010550 · Cited by 765 · see citing works

Free Radical Pathways in CNS Injury

LEWÉN, A., MATZ, P., & CHAN, P. H. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.871 · Cited by 759 · see citing works

Conversion of Zonulae Occludentes from Tight to Leaky Strand Type by Introducing Claudin-2 into Madin-Darby Canine Kidney I Cells

Furuse, M., Furuse, K., Sasaki, H., & Tsukita, S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.263 · Cited by 712 · see citing works

Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells

Anderson, A. C., Anderson, D. E., Bregoli, L., Hastings, W. D., Kassam, N., Lei, C., Chandwaskar, R., Kármán, J., Su, E. W., Hirashima, M., et al. (2007) · Science · doi:10.1126/science.1148536 · Cited by 703 · see citing works

Demyelination: The Role of Reactive Oxygen and Nitrogen Species

Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 601 · see citing works

Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier

Upadhyay, R. K. (2014) · BioMed Research International · doi:10.1155/2014/869269 · Cited by 532 · see citing works

The role of nitric oxide in multiple sclerosis

Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531 · see citing works

Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

Ramagopalan, S. V., Maugeri, N., Handunnetthi, L., Lincoln, M. R., Orton, S. M., Dyment, D. A., DeLuca, G. C., Herrera, B. M., Chao, M. J., Sadovnick, A. D., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000369 · Cited by 523 · see citing works

Trafficking of immune cells in the central nervous system

Wilson, E. H., Weninger, W., & Hunter, C. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41911 · Cited by 521 · see citing works

Nanoparticles for Brain Drug Delivery

Masserini, M. (2013) · ISRN Biochemistry · doi:10.1155/2013/238428 · Cited by 492 · see citing works

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme

Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 490 · see citing works

Oxidative stress in Alzheimer disease: A possibility for prevention

Bonda, D., Wang, X., Perry, G. L., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 481 · see citing works

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.

Bagasra, O., Michaels, F. H., Zheng, Y., Bobroski, L. E., Spitsin, S. V., Fu, Z., Tawadros, R., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12041 · Cited by 456 · see citing works

Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme

Wolburg, H., Wolburg‐Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454 · see citing works

Induction of MHC Class I Genes in Neurons

Neumann, H., Cavalié, A., Jenne, D. E., & Wekerle, H. (1995) · Science · doi:10.1126/science.7624779 · Cited by 449 · see citing works

Neurological Diseases in Relation to the Blood–Brain Barrier

Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 442 · see citing works

T cells become licensed in the lung to enter the central nervous system

Odoardi, F., Sie, C., Streyl, K., Ulaganathan, V. K., Schläger, C., Lodygin, D., Heckelsmiller, K., Nietfeld, W., Ellwart, J. W., Klinkert, W. E. F., et al. (2012) · Nature · doi:10.1038/nature11337 · Cited by 440 · see citing works

The role of shear stress in Blood-Brain Barrier endothelial physiology

Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., & Janigro, D. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-40 · Cited by 437 · see citing works

Drug delivery to the central nervous system: a review.

Misra, A. R., Ganesh, S. D., Shahiwala, A., & Shah, S. P. (2003) · PubMed · Cited by 434 · see citing works

Mechanisms of the Antioxidant Effects of Nitric Oxide

Wink, D. A., Miranda, K. M., Espey, M. G., Pluta, R. M., Hewett, S. J., Colton, C. A., Vitek, M. P., Feelisch, M., & Grisham, M. B. (2001) · Antioxidants and Redox Signaling · doi:10.1089/152308601300185179 · Cited by 400 · see citing works

Drug delivery to the central nervous system: A review

Tamargo, R. J., & Brem, H. (1992) · Neurosurgery Quarterly · Cited by 370 · see citing works

Tight junction modulation and its relationship to drug delivery

SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357 · see citing works

Disruption of central nervous system barriers in multiple sclerosis

Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334 · see citing works

Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab

Steinman, L. (2005) · Nature reviews. Drug discovery · doi:10.1038/nrd1752 · Cited by 328 · see citing works

Astrocytes in multiple sclerosis: A product of their environment

Nair, A., Frederick, T., & Miller, S. D. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8059-5 · Cited by 312 · see citing works

B cells and multiple sclerosis

Franciotta, D. M., Salvetti, M., Lolli, F., Serafini, B., & Aloisi, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70192-3 · Cited by 286 · see citing works

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination

Rostami, A. M., & Ćirić, B. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.002 · Cited by 275 · see citing works

The Structure and Function of Claudins, Cell Adhesion Molecules at Tight Junctions

Tsukita, S., & Furuse, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05235.x · Cited by 247 · see citing works

The blood-brain barrier, chemokines and multiple sclerosis

Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247 · see citing works

Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242 · see citing works

Macrophages and neurodegeneration

Hendriks, J. J. A., Teunissen, C. E., de Vries, H. E., & Dijkstra, C. D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.008 · Cited by 241 · see citing works

Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI

Cramer, S. P., Simonsen, H., Frederiksen, J. L., Rostrup, E., & Larsson, H. B. W. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.12.001 · Cited by 232 · cited 1× · see citing works

Inflammatory mediators in demyelinating disorders of the CNS and PNS

Hartung, H., Jung, S., Stoll, G., Zielasek, J., Schmidt, B. G., Archelos, J. J., & Toyka, K. V. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90134-7 · Cited by 213 · see citing works

Astrocyte–neuron interactions in neurological disorders

Ricci, G., Volpi, L., Pasquali, L., Petrozzi, L., & Siciliano, G. (2009) · Journal of Biological Physics · doi:10.1007/s10867-009-9157-9 · Cited by 205 · see citing works

Remyelination in multiple sclerosis

Lassmann, H., Brück, W., Lucchinetti, C., & Rodriguez, M. (1997) · Multiple Sclerosis Journal · doi:10.1177/135245859700300213 · Cited by 191 · see citing works

The Crosstalk between the Bone and the Immune System: Osteoimmunology

Brunetti, G., Mori, G., D’Amelio, P., & Faccio, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/617319 · Cited by 188 · see citing works

Recent Advances in Blood–Brain Barrier Disruption as a CNS Delivery Strategy

Bellavance, M., Blanchette, M., & Fortin, D. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9018-7 · Cited by 183 · see citing works

Reactive oxygen species are required for the phagocytosis of myelin by macrophages

van der Goes, A., Brouwer, J. P., Hoekstra, K., Roos, D., van den Berg, T. K., & Dijkstra, C. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00175-1 · Cited by 180 · see citing works

Multiple Sclerosis and Regulatory T Cells

Costantino, C. M., Baecher‐Allan, C., & Hafler, D. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9236-x · Cited by 167 · see citing works

Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity

Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., van Kesteren-Hendrikx, E. M. L., Döpp, E. A., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167 · see citing works

Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S‐nitrosothiols and with changes in glutathione levels

Calabrese, V., Scapagnini, G., Ravagna, A., Bella, R., Foresti, R., Bates, T. E., Stella, A. G., & Pennisi, G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10408 · Cited by 162 · see citing works

Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro

van der Goes, A., Wouters, D., van der Pol, S. M. A., Huizinga, R., Ronken, E., Adamson, P., Greenwood, J., Dijkstra, C. D., & de Vries, H. E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0881fje · Cited by 162 · see citing works

Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis

Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160 · see citing works

Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage

Hill, K. E., Zollinger, L. V., Watt, H. E., Carlson, N. G., & Rose, J. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.005 · Cited by 158 · see citing works

Natalizumab: Targeting α4-Integrins in Multiple Sclerosis

Engelhardt, B., & Kappos, L. (2007) · Neurodegenerative Diseases · doi:10.1159/000109933 · Cited by 154 · see citing works

Local Overexpression of V1a-Vasopressin Receptor Enhances Regeneration in Tumor Necrosis Factor-Induced Muscle Atrophy

Costa, A., Toschi, A., Murfuni, I., Pelosi, L., Sica, G., Adamo, S., & Scicchitano, B. M. (2014) · BioMed Research International · doi:10.1155/2014/235426 · Cited by 134 · see citing works

Cytokine‐stimulated inducible nitric oxide synthase expression in astroglia: Role of Erk mitogen‐activated protein kinase and NF‐κB

Marcus, J. S., Karackattu, S. L., Fleegal, M. A., & Sumners, C. (2002) · Glia · doi:10.1002/glia.10168 · Cited by 120 · see citing works

The potential role of nitric oxide in multiple sclerosis

Giovannoni, G., Heales, S., Land, J. M., & Thompson, E. J. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400323 · Cited by 113 · see citing works

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response

Hernández‐Pedro, N., Espinosa-Ramírez, G., de la Cruz, V. P., Pineda, B., & Sotelo, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/413465 · Cited by 108 · see citing works

IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS

Waubant, E. L., Goodkin, D., Bostrom, A., Bacchetti, P., Hietpas, J., Lindberg, R. L. P., & Leppert, D. (2003) · Neurology · doi:10.1212/wnl.60.1.52 · Cited by 105 · see citing works

Drug Transport into the Mammalian Brain: The Nasal Pathway and its Specific Metabolic Barrier

Minn, A., Leclerc, S., Heydel, J., Minn, A.-L., Denizot, C., Cattarelli, M., Netter, P., & Grădinaru, D. (2002) · Journal of drug targeting · doi:10.1080/713714452 · Cited by 104 · see citing works

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis,

Shinto, L. H., Marracci, G., Baldauf-Wagner, S., Strehlow, A., Yadav, V., Stuber, L. E., & BOURDETTE, D. N. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.12.001 · Cited by 88 · see citing works

Regulation of claudins in blood-tissue barriers under physiological and pathological states

Gonçalves, A., Ambrósio, A. F., & Fernandes, R. (2013) · Tissue Barriers · doi:10.4161/tisb.24782 · Cited by 85 · see citing works

Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease

Meeteren, M. E. V., Hendriks, J. J. A., Dijkstra, C. D., & van Tol, E. A. F. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.018 · Cited by 84 · see citing works

Role of puberty in multiple sclerosis risk and course

Chitnis, T. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.03.014 · Cited by 84 · see citing works

Environmental triggers of multiple sclerosis

Kakalacheva, K., & Lünemann, J. D. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.006 · Cited by 83 · see citing works

Promoting Remyelination in Multiple Sclerosis—Recent Advances

Muenzel, E. J., & Williams, A. (2013) · Drugs · doi:10.1007/s40265-013-0146-8 · Cited by 83 · see citing works

The Role of ER Stress-Induced Apoptosis in Neurodegeneration

Stefani, I. C., Wright, D., Polizzi, K. M., & Kontoravdi, C. (2012) · Current Alzheimer Research · doi:10.2174/156720512800107618 · Cited by 83 · see citing works

H2O2-mediated permeability II: importance of tyrosine phosphatase and kinase activity

Kevil, C. G., Okayama, N., & Alexander, J. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.6.c1940 · Cited by 74 · see citing works

Functions of lipid raft membrane microdomains at the blood–brain barrier

Dodelet-Devillers, A., Cayrol, R., van Horssen, J., Haqqani, A. S., de Vries, H. E., Engelhardt, B., Greenwood, J., & Prat, A. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0488-6 · Cited by 70 · see citing works

Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1

Sadowski, T., & Steinmeyer, J. (2001) · Inflammation Research · doi:10.1007/s000110050742 · Cited by 67 · see citing works

Oxidative Stress is Increased in Serum from Mexican Patients with Relapsing-Remitting Multiple Sclerosis

Ortíz, G. G., Macías-Islas, M. Á., Pacheco-Moisés, F. P., Cruz-Ramos, J. A., Sustersik, S., Barba, E. A., & Arelis, A. A. (2009) · Disease Markers · doi:10.1155/2009/325847 · Cited by 66 · see citing works

Molecular Basis of Leukocyte–Endothelium Interactions During the Inflammatory Response

Barreiro, O., & Sánchez‐Madrid, F. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71837-7 · Cited by 56 · see citing works

Phosphorylation of Blood Vessel Vasodilator-Stimulated Phosphoprotein at Serine 239 as a Functional Biochemical Marker of Endothelial Nitric Oxide/Cyclic GMP Signaling

Ibarra‐Alvarado, C., Galle, J., Melichar, V. O., Mameghani, A. T., & Schmidt, H. H. H. W. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.2.312 · Cited by 56 · see citing works

Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis.

Ortíz, G. G., Macías-Islas, M. Á., Pacheco-Moisés, F. P., et al. (2009) · PubMed · doi:10.3233/dma-2009-0602 · Cited by 53 · see citing works

Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis

Scott, G. S., Hake, P. W., Kean, R. B., Virág, L., Szabó, C., & Hooper, D. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00329-0 · Cited by 51 · see citing works

Is MS an inflammatory or primary degenerative disease?

Losy, J. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1079-9 · Cited by 50 · see citing works

Bases moleculares de las interacciones leucocito-endotelio durante la respuesta inflamatoria

Barreiro, O., & Sánchez‐Madrid, F. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)71035-8 · Cited by 47 · see citing works

Pro-inflammatory cytokines intensify the activation of NO/NOS, JNK1/2 and caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin

Vaz, A. R., Silva, S. L., Barateiro, A. P., Fernandes, A. M. A., Falcão, A. S., Brito, M. A., & Brites, D. M. T. O. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.004 · Cited by 46 · see citing works

Methylprednisolone Acts on Peripheral Blood Mononuclear Cells and Endothelium in Inhibiting Migration Phenomena in Patients With Multiple Sclerosis

Gelati, M. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.774 · Cited by 45 · see citing works

Microglia: a cellular vehicle for CNS gene therapy

Neumann, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30230 · Cited by 41 · see citing works

“Thinking without thinking” about natalizumab and PML

Ransohoff, R. M. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.04.011 · Cited by 33 · see citing works

Immune tolerance and control of CNS autoimmunity: from animal models to MS patients

Cassan, C., & Liblau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04270.x · Cited by 32 · see citing works

Investigation of endosomal compartments involved in endocytosis and transcytosis of polymeric immunoglobulin A by subcellular fractionation of perfused isolated rat liver

Perez, J. H., Branch, W. J., Smith, L., Mullock, B. M., & Luzio, J. P. (1988) · Biochemical Journal · doi:10.1042/bj2510763 · Cited by 29 · see citing works

Multiple Redox Regulation of the Cellular Signaling System Linked to AP‐1 and NFκB: Effects of N‐Acetylcysteine and H2O2 on the Receptor Tyrosine Kinases, the MAP Kinase Cascade, and IκB Kinases

Kamata, H., Manabe, T., Kakuta, J., Oka, S., & Hirata, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04675.x · Cited by 27 · see citing works

The initiation of the autoimmune response in multiple sclerosis

Markovic‐Plese, S., Pinilla, C., & Martinꝉ, R. (2004) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2004.02.018 · Cited by 24 · see citing works

A study of the hydrogen ion concentration of the potato tuber

Robertson, I. M., & Smith, A. M. (1931) · Biochemical Journal · doi:10.1042/bj0250763 · Cited by 21 · see citing works

Natalizumab: overview of its pharmacology and safety.

Baker, D. E. (2007) · PubMed · Cited by 20 · see citing works

Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)

Spuch, C., & Fernández-Balbuena, C. N. (2010) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214811004030190 · Cited by 18 · see citing works

La barrera hematoencefálica y la administración de medicamentos en el sistema nervioso central

Neckel, G. L., & Koepp, J. (2010) · Revista de Neurología · doi:10.33588/rn.5103.2009166 · Cited by 15 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Multiple sclerosis

Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562 · see citing works

Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology

Augustin, H. G., & Koh, G. Y. (2017) · Science · doi:10.1126/science.aal2379 · Cited by 762 · see citing works

The blood-brain barrier in aging and neurodegeneration

Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738 · see citing works

Identification of tissue-specific cell death using methylation patterns of circulating DNA

Lehmann‐Werman, R., Neiman, D., Zemmour, H., Moss, J., Magenheim, J., Vaknin‐Dembinsky, A., Rubertsson, S., Nellgård, B., Blennow, K., Zetterberg, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519286113 · Cited by 618 · see citing works

Macrophage polarization: an important role in inflammatory diseases

Luo, M., Zhao, F., Cheng, H., Su, M., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352946 · Cited by 515 · see citing works

Microglia–blood vessel interactions: a double-edged sword in brain pathologies

Dudvarski Stankovic, N., Teodorczyk, M., Ploen, R., Zipp, F., & Schmidt, M. H. H. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1524-y · Cited by 301 · see citing works

A computational tool (H-MAGMA) for improved prediction of brain-disorder risk genes by incorporating brain chromatin interaction profiles

Sey, N. Y. A., Hu, B., Mah, W., Fauni, H., McAfee, J. C., Rajarajan, P., Brennand, K. J., Akbarian, S., & Won, H. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0603-0 · Cited by 297 · see citing works

Selenium, selenoproteins and neurodegenerative diseases

Cardoso, B. R., Roberts, B. R., Bush, A. I., & Hare, D. J. (2015) · Metallomics · doi:10.1039/c5mt00075k · Cited by 295 · see citing works

Exercise as Medicine in Multiple Sclerosis—Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives

Dalgas, U., Langeskov‐Christensen, M., Stenager, E., Riemenschneider, M., & Hvid, L. G. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-1002-3 · Cited by 292 · see citing works

Leaky Gut, Leaky Brain?

Obrenovich, M. E. (2018) · Microorganisms · doi:10.3390/microorganisms6040107 · Cited by 258 · see citing works

Brain and Retinal Pericytes: Origin, Function and Role

Trost, A., Lange, S., Schroedl, F., Bruckner, D., Motloch, K. A., Bogner, B., Kaser-Eichberger, A., Strohmaier, C., Runge, C., Aigner, L., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00020 · Cited by 244 · see citing works

WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective

Ramakrishna, K., Nalla, L. V., Dumala, N., Venkateswarlu, K., Viswanadh, M. K., Nalluri, B. N., Chakravarthy, G., Duguluri, S., Singh, P., Nand, S., et al. (2023) · Diseases · doi:10.3390/diseases11030089 · Cited by 203 · see citing works

The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics

Camara-Lemarroy, C. R., Metz, L. M., Meddings, J. B., Sharkey, K. A., & Yong, V. W. (2018) · Brain · doi:10.1093/brain/awy131 · Cited by 188 · see citing works

Vascular Endothelial Cells: Heterogeneity and Targeting Approaches

Hennigs, J. K., Matuszcak, C., Trepel, M., & Körbelin, J. (2021) · Cells · doi:10.3390/cells10102712 · Cited by 188 · see citing works

Pericytes regulate vascular immune homeostasis in the CNS

Török, O., Schreiner, B., Schaffenrath, J., Tsai, H.-C., Maheshwari, U., Stifter, S. A., Welsh, C., Amorim, A., Sridhar, S., Utz, S. G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016587118 · Cited by 166 · see citing works

Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment

Bălașa, R., Bărcuţean, L., Mosora, O., & Manu, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168370 · Cited by 160 · see citing works

Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders

Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152 · see citing works

Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis

Zheng, C., Chen, J., Chu, F., Zhu, J., & Jin, T. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00314 · Cited by 150 · see citing works

Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology

Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works

Blood brain barrier: A review of its anatomy and physiology in health and disease

Sharif, Y., Jumah, F., Coplan, L., Krosser, A., Sharif, Κ., & Tubbs, R. S. (2018) · Clinical Anatomy · doi:10.1002/ca.23083 · Cited by 143 · see citing works

Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers

Ramirez, S. H., Andrews, A. M., Paul, D., & Pachter, J. S. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0104-7 · Cited by 139 · see citing works

Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders

Alajangi, H. K., Kaur, M., Sharma, A., Rana, S., Thakur, S., Chatterjee, M., Singla, N., Jaiswal, P. K., Singh, G., & Barnwal, R. P. (2022) · Molecular Brain · doi:10.1186/s13041-022-00937-4 · Cited by 130 · see citing works

Breaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction

Gryka-Marton, M., Grabowska, A. D., & Szukiewicz, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083532 · Cited by 137 · see citing works

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction

Kooij, G., Troletti, C. D., Leuti, A., Norris, P. C., Riley, I. R., Albanese, M., Ruggieri, S., Libreros, S., van der Pol, S. M. A., Hof, B. V. H., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.219519 · Cited by 120 · see citing works

Activated Microglia Disrupt the Blood-Brain Barrier and Induce Chemokines and Cytokines in a Rat in vitro Model

Shigemoto‐Mogami, Y., Hoshikawa, K., & Sato, K. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00494 · Cited by 118 · see citing works

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders

Xiao, M., Xiao, Z. J., Yang, B., Lan, Z., & Fang, F. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00764 · Cited by 113 · see citing works

Therapeutic potential of curcumin for multiple sclerosis

Qureshi, M., Al-Suhaimi, E. A., Wahid, F., Shehzad, O., & Shehzad, A. (2017) · Neurological Sciences · doi:10.1007/s10072-017-3149-5 · Cited by 112 · see citing works

The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis

Bălașa, R., Bărcuţean, L., Bălașa, A. F., Moțățăianu, A., Roman-Filip, C., & Manu, D. R. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.009 · Cited by 111 · see citing works

Blood–brain barrier and its function during inflammation and autoimmunity

Sonar, S. A., & Lal, G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru1117-428r · Cited by 108 · see citing works

Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology

Mayer-Pröschel, M., Hogestyn, J. M., & Mock, D. J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.226380 · Cited by 105 · see citing works

Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis

Sánchez-López, A. L., Ortíz, G. G., Pacheco-Moisés, F. P., Mireles-Ramírez, M. A., Bitzer-Quintero, O. K., Delgado-Lara, D. L. C., Ramírez-Jirano, L. J., & Velázquez-Brizuela, I. E. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.12.004 · Cited by 100 · see citing works

TIMP1 preserves the blood–brain barrier through interacting with CD63/integrin 1 complex and regulating downstream FAK/RhoA signaling

Tang, J., Kang, Y., Huang, L., Wu, L., & Peng, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.015 · Cited by 98 · see citing works

Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond

Wang, X., Li, G., Guo, J., Zhang, Z., Zhang, S., Zhu, Y., Cheng, J., Yu, L., Ji, Y., & Tao, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01393 · Cited by 93 · see citing works

Neuroinflammation: A Signature or a Cause of Epilepsy?

Pracucci, E., Pillai, V., Lamers, D., Parra, R., & Landi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136981 · Cited by 94 · see citing works

A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches

Bashinskaya, V. V., Кулакова, О. Г., Boyko, A. N., Favorov, A. V., & Favorova, O. O. (2015) · Human Genetics · doi:10.1007/s00439-015-1601-2 · Cited by 92 · see citing works

Sex differences in the blood–brain barrier and neurodegenerative diseases

Weber, C. M., & Clyne, A. M. (2021) · APL Bioengineering · doi:10.1063/5.0035610 · Cited by 91 · see citing works

Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform

Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 94 · see citing works

Astrocytes contribute to Aβ‐induced blood–brain barrier damage through activation of endothelial <scp>MMP</scp> 9

Spampinato, S. F., Merlo, S., Sano, Y., Kanda, T., & Sortino, M. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14068 · Cited by 90 · see citing works

S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis

Barateiro, A. P., Afonso, V., Santos, G., Cerqueira, J., Brites, D. M. T. O., van Horssen, J., & Fernandes, A. M. A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9336-6 · Cited by 90 · see citing works

From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum

Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 87 · see citing works

Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases

Babazadeh, A., Vahed, F. M., & Jafari, S. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.015 · Cited by 89 · see citing works

Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models

Brandl, S., & Reindl, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612699 · Cited by 93 · see citing works

Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke

Sarvari, S., Moakedi, F., Hone, E., Simpkins, J. W., & Ren, X. S. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00573-8 · Cited by 84 · see citing works

Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells

Lee, M. J., Jang, M., Choi, J., Chang, B. S., ‍Kim, D. Y., Kim, S., Kwak, Y.-S., Oh, S., Lee, J., Chang, B., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9131-4 · Cited by 82 · see citing works

Exercise and Neuroinflammation in Health and Disease

Seo, D.-Y., Heo, J.-W., Ko, J. R., & Kwak, H.-B. (2019) · International Neurourology Journal · doi:10.5213/inj.1938214.107 · Cited by 88 · see citing works

Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis

Wetzels, S., Wouters, K., Schalkwijk, C. G., Vanmierlo, T., & Hendriks, J. J. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020421 · Cited by 80 · see citing works

Blood–Brain Barrier Disruption in Neuroimmunological Disease

Shimizu, F., & Nakamori, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910625 · Cited by 82 · see citing works

Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

Uher, T., McComb, M., Galkin, S., Srpova, B., Oechtering, J., Barro, C., Tyblova, M., Bergsland, N., Krasensky, J., Dwyer, M., et al. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458520912379 · Cited by 86 · see citing works

Lipid nanocapsules to enhance drug bioavailability to the central nervous system

Moura, R. P., Pacheco, C., Pêgo, A. P., Rieux, A. D., & Sarmento, B. F. C. C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.042 · Cited by 72 · see citing works

Promising Nanotechnology Approaches in Treatment of Autoimmune Diseases of Central Nervous System

Chountoulesi, M., & Demetzos, C. (2020) · Brain Sciences · doi:10.3390/brainsci10060338 · Cited by 74 · see citing works

Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis

Meier, U., Cipian, R. C., Karimi, A., Ramasamy, R., & Middeldorp, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757302 · Cited by 75 · see citing works

The restorative role of annexin A1 at the blood–brain barrier

McArthur, S., Loiola, R. A., Maggioli, E., Errede, M., Virgintino, D., & Solito, E. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0043-0 · Cited by 71 · see citing works

Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders

Hensel, N., Rademacher, S., & Claus, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00198 · Cited by 69 · see citing works

Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients

Fellows, K., Uher, T., Browne, R. W., Weinstock‐Guttman, B., Horáková, D., Posová, H., Vaněčková, M., Seidl, Z., Krásenský, J., Týblová, M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060970 · Cited by 68 · see citing works

Biosensors Integration in Blood–Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases

Mir, M., Palma-Florez, S., Lagunas, A., Lopez-Martinez, M. J., & Samitier, J. (2022) · ACS Sensors · doi:10.1021/acssensors.2c00333 · Cited by 67 · see citing works

Heterogeneous astrocytes: Active players in CNS

Hu, X., Yuan, Y., Wang, D., & Su, Z. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.017 · Cited by 66 · see citing works

IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier

Lee, M. J., Bing, S. J., Choi, J., Jang, M., Lee, G., Lee, H., Chang, B. S., Jee, Y., Lee, S. J., & Cho, I. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0116-1 · Cited by 67 · see citing works

Exercise-induced changes in neurotrophic factors and markers of blood-brain barrier permeability are moderated by weight status in multiple sclerosis.

Mokhtarzade, M., Motl, R., Negaresh, R., Zimmer, P., Khodadoost, M., Baker, J., Patel, D. I., Majdinasab, N., & Ranjbar, R. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.05.010 · Cited by 25 · see citing works

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?

Brancati, S. B., Gozzo, L., Longo, L., Vitale, D. C., & Drago, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661882 · Cited by 65 · see citing works

Immune Regulation of Antibody Access to Neuronal Tissues

Iwasaki, A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.004 · Cited by 64 · see citing works

A Comprehensive View on MRI Techniques for Imaging Blood-Brain Barrier Integrity.

Elschot, E. P., Backes, W., Postma, A., van Oostenbrugge, R. V., Staals, J., Rouhl, R., & Jansen, J. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000723 · Cited by 54 · see citing works

Blood-brain barrier models: Rationale for selection

Hanafy, A. S., Dietrich, D., Fricker, G., & Lamprecht, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113859 · Cited by 58 · see citing works

The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects

Al-Kuraishy, H. M., Al-Gareeb, A. I., Saad, ‏. M., & Batiha, G. E. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01240-x · Cited by 54 · see citing works

A strocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis

Eilam, R., Segal, M., Malach, R., Sela, M., Arnon, R., & Aharoni, R. (2018) · Glia · doi:10.1002/glia.23304 · Cited by 53 · see citing works

The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis

Angelini, G., Bani, A., Constantin, G., & Rossi, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1101379 · Cited by 55 · see citing works

Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis

Ghalamfarsa, G., Hojjat‐Farsangi, M., Mohammadnia‐Afrouzi, M., Anvari, E., Farhadi, S., Yousefi, M., & Jadidi‐Niaragh, F. (2016) · Journal of Immunotoxicology · doi:10.3109/1547691x.2016.1159264 · Cited by 53 · see citing works

Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers

Verreycken, J., Baeten, P., & Broux, B. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2153534 · Cited by 58 · see citing works

Altered astrocytic function in experimental neuroinflammation and multiple sclerosis

das Neves, S. P., Sousa, J. C., Sousa, N., Cerqueira, J., & Marques, F. (2020) · Glia · doi:10.1002/glia.23940 · Cited by 47 · see citing works

Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis

Rosenstein, I., Axelsson, M., Novakova, L., Malmeström, C., Blennow, K., Zetterberg, H., & Lycke, J. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11817-9 · Cited by 49 · see citing works

A human-on-a-chip approach to tackling rare diseases

de Mello, C. P. P., Rumsey, J. W., Slaughter, V. L., & Hickman, J. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.08.001 · Cited by 48 · see citing works

Pericytes Across the Lifetime in the Central Nervous System

Bennett, H. C., & Kim, Y. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.627291 · Cited by 47 · see citing works

Barrier-on-a-Chip with a Modular Architecture and Integrated Sensors for Real-Time Measurement of Biological Barrier Function

Zoio, P., Lopes‐Ventura, S., & Oliva, A. (2021) · Micromachines · doi:10.3390/mi12070816 · Cited by 48 · see citing works

Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM

Deh, K., Ponath, G. D., Molvi, Z., Parel, S. T., Gillen, K. M., Zhang, S., Nguyen, T. D., Spincemaille, P., Ma, Y., Gupta, A. K., et al. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25997 · Cited by 48 · see citing works

Dietary Polyphenols as a Protection against Cognitive Decline: Evidence from Animal Experiments; Mechanisms and Limitations

Naomi, R., Yazid, M. D., Teoh, S. H., Balan, S. S., Halim, S., Kumar, J., Bahari, H., & Embong, H. (2023) · Antioxidants · doi:10.3390/antiox12051054 · Cited by 47 · see citing works

Implicating neuroinflammation in hippocampus, prefrontal cortex and amygdala with cognitive deficit: a narrative review

Blossom, V., Ullal, S. D., D’Souza, M. M., Ranade, A. V., Kumar, N. A., & Rai, R. (2025) · 3 Biotech · doi:10.1007/s13205-025-04468-2 · Cited by 54 · see citing works

Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence

Bayat, P., Farshchi, M., Yousefian, M., Mahmoudi, M., & Robati, R. Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107562 · Cited by 47 · see citing works

miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability

Harati, R., Hammad, S., Tlili, A., Mahfood, M., Mabondzo, A. M., & Hamoudi, R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262152 · Cited by 48 · see citing works

IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis

Ghalamfarsa, G., Mahmoudi, M., Mohammadnia‐Afrouzi, M., Yazdani, Y., Anvari, E., Hadinia, A., Ghanbari, A., Setayesh, M., Yousefi, M., & Jadidi‐Niaragh, F. (2015) · Journal of Immunotoxicology · doi:10.3109/1547691x.2015.1089343 · Cited by 46 · see citing works

Mfsd2a-based pharmacological strategies for drug delivery across the blood–brain barrier

Wang, J.-Z., Xiao, N., Zhang, Y.-Z., Zhao, C., Guo, X., & Lu, L.-M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.024 · Cited by 45 · see citing works

BDNF and Tau as Biomarkers of Severity in Multiple Sclerosis

Islas‐Hernández, A., Aguilar-Talamantes, H., Bertado-Cortés, B., Mejia-delCastillo, G. D. J., Carrera-Pineda, R., Cuevas-García, C., & Torre, P. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0374 · Cited by 44 · see citing works

siRNA Therapeutics: Future Promise for Neurodegenerative Diseases

Amiri, A., Barreto, G. E., Sathyapalan, T., & Sahebkar, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210402104054 · Cited by 45 · see citing works

Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis

Correale, J. D., Halfón, M. J., Jack, D. L., Rubstein, A., & Villa, A. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103264 · Cited by 46 · see citing works

Unveiling the role of gut-brain axis in regulating neurodegenerative diseases: A comprehensive review

Yadav, H., Jaldhi, Bhardwaj, R., Anamika, A., Bakshi, A., Gupta, S., & Maurya, S. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122022 · Cited by 46 · see citing works

Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis

Fan, L., Yang, J., Liu, R.-Y., Kong, Y., Guo, G., & Xu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04516-6 · Cited by 44 · see citing works

Imaging B Cells in a Mouse Model of Multiple Sclerosis Using 64Cu-Rituximab PET

James, M. L., Höhne, A., Mayer, A. T., Lechtenberg, K. J., Moreno, M. A., Gowrishankar, G., Ilovich, O., Natarajan, A., Johnson, E. M., Nguyen, J., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189597 · Cited by 44 · see citing works

CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis

Mazzucco, M. R., Mannheim, W., Shetty, S. V., & Linden, J. R. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00299-4 · Cited by 44 · see citing works

From pathology to MRI and back: Clinically relevant biomarkers of multiple sclerosis lesions

Kolb, H., Al‐Louzi, O., Beck, E., Sati, P., Absinta, M., & Reich, D. S. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103194 · Cited by 43 · see citing works

MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro

Cerutti, C., Soblechero‐Martín, P., Wu, D., Lopez‐Ramirez, M. A., de Vries, H. E., Sharrack, B., Male, D. K., & Romero, I. A. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0032-3 · Cited by 42 · see citing works

Ginsenoside-Re inhibits experimental autoimmune encephalomyelitis as a mouse model of multiple sclerosis by downregulating TLR4/MyD88/NF-κB signaling pathways

Oh, J., Kwon, T. W., Choi, J. H., Kim, Y., Moon, S., Nah, S.-Y., & Cho, I. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155065 · Cited by 41 · see citing works

Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?

Broos, J. Y., van der Burgt, R. T. M., Konings, J., Rijnsburger, M., Werz, O., de Vries, H. E., Giera, M., & Kooij, G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02981-w · Cited by 41 · see citing works

Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood–brain barrier

Shamul, J. G., Wang, Z., Gong, H., Ou, W., White, A. M., Garcia, D. P. M., Gu, S., Clyne, A. M., Quiñones‐Hinojosa, A., & He, X. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01250-2 · Cited by 42 · see citing works

Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation

Roggeri, A., Schepers, M., Tiane, A., Rombaut, B., van Veggel, L., Hellings, N., Prickaerts, J., Pittaluga, A., & Vanmierlo, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207537 · Cited by 40 · see citing works

Voltage-gated potassium channel 1.3: A promising molecular target in multiple disease therapy

Cheng, S., Jiang, D., Lan, X., Liu, K., & Fan, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116651 · Cited by 42 · see citing works

Overcoming Barriers in Glioblastoma—Advances in Drug Delivery Strategies

ter Linden, E., Abels, E. R., van Solinge, T. S., Neefjes, J., & Broekman, M. L. D. (2024) · Cells · doi:10.3390/cells13120998 · Cited by 40 · see citing works

Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation

Aarts, S. A. B. M., Seijkens, T. T. P., Kusters, P. J. H., van der Pol, S. M. A., Zarzycka, B. A., Heijnen, P. D. A. M., Beckers, L., den Toom, M., Gijbels, M. J., Boon, L., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0875-9 · Cited by 40 · see citing works

Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles

D’Egidio, F., Castelli, V., d’Angelo, M., Ammannito, F., Quintiliani, M., & Cimini, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106663 · Cited by 39 · see citing works

Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis

Jonas, S. N., Izbudak, I., Frazier, A. A., & Harrison, D. M. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5796 · Cited by 39 · see citing works

Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis

Kunkl, M., Amormino, C., Tedeschi, V., Fiorillo, M. T., & Tuosto, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824411 · Cited by 43 · see citing works

ZO-1 expression is suppressed by GM-CSF via miR-96/ERG in brain microvascular endothelial cells

Zhang, H., Zhang, S., Zhang, J., Liu, D., Wei, J., Fang, W., Zhao, W., Chen, Y., & Shang, D. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17702668 · Cited by 37 · see citing works

Blood-brain barrier disruption in multiple sclerosis

Minagar, A., & Alexander, J. S. (2003) · Multiple Sclerosis · doi:10.1191/1352458503ms965oa · Cited by 685 · see citing works

Blood-brain barrier disruption in multiple sclerosis. Multiple Sclerosis 9:540–549

Minagar, A., & Alex, J. S. (2003)

Mechanisms of Blood–Brain Barrier Disintegration in the Pathophysiology of Multiple Sclerosis

Stevenson, E. V., Alexander, J. S., Yun, J. W., Becker, F., Gonzalez‐Toledo, E., & Minagar, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00016-6 · Cited by 7 · see citing works

Blood-brain barrier disruption in multiple sclerosis, Multiple Sclerosis 9 (2003), 540–549. E. Waubant / Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis 243

Minagar, A., & Alex, J. S. (2016)

Magnetic Resonance and Blood-Brain Barrier Dysfunction in Multiple Sclerosis

Rovaris, M., Tortorella, C., Sipe, J. C., & Filippi, M. (1999) · Springer eBooks · doi:10.1007/978-88-470-2143-3_19